首页 > 最新文献

Homeopathy最新文献

英文 中文
Effectiveness of Eupatorium Perfoliatum 30C in Preventing Dengue Fever-A Prospective, Community-Based, Open Label, Parallel Cohort Study in Delhi, India. 在印度德里开展的一项以社区为基础的前瞻性、开放标签、平行队列研究--30C 欧鼠李对预防登革热的功效。
IF 1.2 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-01 Epub Date: 2024-10-24 DOI: 10.1055/s-0044-1788663
Debadatta Nayak, Lovepreet Kaur, Rupali Bhalerao, Karanpreet Nahar, Hanuman Ram, Pawan Sharma, Ankit Gupta, Smita Singh, Anil Khurana, Raj Kumar Manchanda

Objective:  The study was undertaken to evaluate the protective effect of Eupatorium perfoliatum (EP) 30C on the incidence of dengue fever.

Design:  This study was designed as a prospective, open label, parallel cohort study.

Interventions:  Participants were enrolled in two medicine cohort (MC) communities and one control cohort (CC) community. Participants in MC who were more than 5 years of age received four medicated globules and those aged between 1 and 5 years received two medicated globules of EP 30C once a week for 10 weeks. Participants in CC received no medical intervention. Both cohorts received information and educational material regarding dengue.

Outcome measures:  The primary outcome was incidence of dengue cases based on laboratory confirmation or the clinical definition of dengue as per the case definition notified by the National Vector-Borne Disease Control Program, Government of India, during the 14 weeks of intervention and observation.

Results:  The analysis included 20,607 participants residing in three slums of Delhi, of which MC and CC included 15,298 and 5,309 participants respectively. The overall protective effect of EP 30C in MC against probable/laboratory-confirmed dengue was 59.59% (95% confidence interval [CI], 50.74 to 66.85, p = 0.0001). The overall protective effect of EP 30C against laboratory-confirmed dengue was 72.78% (95% CI, 54.45 to 83.74, p = 0.0001): 26 cases per 15,298 (0.13 per 1,000 person-weeks) in MC versus 33 cases per 5,309 (0.46 per 1,000 person-weeks) in CC.

Conclusion:  The use of EP 30C was associated with some protection against probable and laboratory-confirmed dengue.

研究目的本研究旨在评估 30C 茵陈对登革热发病率的保护作用:本研究是一项前瞻性、开放标签、平行队列研究:干预措施:参与者被纳入两个药物队列(MC)社区和一个对照队列(CC)社区。5岁以上的MC参与者接受4粒药球治疗,1至5岁的参与者接受2粒EP 30C药球治疗,每周一次,持续10周。CC组的参与者没有接受任何医疗干预。两组参与者都收到了有关登革热的信息和教育材料:主要结果是在 14 周的干预和观察期间,根据实验室确认的登革热病例发生率,或根据印度政府国家病媒传播疾病控制计划公布的登革热病例临床定义的发生率:分析包括居住在德里三个贫民窟的 20,607 名参与者,其中 MC 和 CC 分别包括 15,298 和 5,309 名参与者。在 MC 中,EP 30C 对可能/实验室确诊登革热的总体保护效果为 59.59%(95% 置信区间 [CI],50.74 至 66.85,p = 0.0001)。EP 30C 对实验室确诊登革热的总体保护效果为 72.78%(95% CI,54.45 至 83.74,p = 0.0001):在 MC 中,每 15,298 人中有 26 例登革热病例(每千人周 0.13 例),而在 CC 中,每 5,309 人中有 33 例登革热病例(每千人周 0.46 例):使用 EP 30C 可在一定程度上预防可能的登革热和实验室确诊的登革热。
{"title":"Effectiveness of Eupatorium Perfoliatum 30C in Preventing Dengue Fever-A Prospective, Community-Based, Open Label, Parallel Cohort Study in Delhi, India.","authors":"Debadatta Nayak, Lovepreet Kaur, Rupali Bhalerao, Karanpreet Nahar, Hanuman Ram, Pawan Sharma, Ankit Gupta, Smita Singh, Anil Khurana, Raj Kumar Manchanda","doi":"10.1055/s-0044-1788663","DOIUrl":"10.1055/s-0044-1788663","url":null,"abstract":"<p><strong>Objective: </strong> The study was undertaken to evaluate the protective effect of <i>Eupatorium perfoliatum</i> (EP) 30C on the incidence of dengue fever.</p><p><strong>Design: </strong> This study was designed as a prospective, open label, parallel cohort study.</p><p><strong>Interventions: </strong> Participants were enrolled in two medicine cohort (MC) communities and one control cohort (CC) community. Participants in MC who were more than 5 years of age received four medicated globules and those aged between 1 and 5 years received two medicated globules of EP 30C once a week for 10 weeks. Participants in CC received no medical intervention. Both cohorts received information and educational material regarding dengue.</p><p><strong>Outcome measures: </strong> The primary outcome was incidence of dengue cases based on laboratory confirmation or the clinical definition of dengue as per the case definition notified by the National Vector-Borne Disease Control Program, Government of India, during the 14 weeks of intervention and observation.</p><p><strong>Results: </strong> The analysis included 20,607 participants residing in three slums of Delhi, of which MC and CC included 15,298 and 5,309 participants respectively. The overall protective effect of EP 30C in MC against probable/laboratory-confirmed dengue was 59.59% (95% confidence interval [CI], 50.74 to 66.85, <i>p</i> = 0.0001). The overall protective effect of EP 30C against laboratory-confirmed dengue was 72.78% (95% CI, 54.45 to 83.74, <i>p</i> = 0.0001): 26 cases per 15,298 (0.13 per 1,000 person-weeks) in MC versus 33 cases per 5,309 (0.46 per 1,000 person-weeks) in CC.</p><p><strong>Conclusion: </strong> The use of EP 30C was associated with some protection against probable and laboratory-confirmed dengue.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"163-172"},"PeriodicalIF":1.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Role of Homeopathic Intervention in Post-COVID Functional Gastrointestinal Disorders: A Case Series of 12 Patient Profiles. 探索顺势疗法干预在 COVID 后功能性胃肠功能紊乱中的作用:12 位患者的病例系列。
IF 1.2 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-01 Epub Date: 2024-08-05 DOI: 10.1055/s-0044-1787003
Hima Bindu Ponnam, Siva Subrahmanyam Chirravuri, Shanmukha Priya Konduru, Swathi Jammalamadaka

Background:  In the last 2 years of the pandemic, a wide range of cases of post-COVID functional gastrointestinal disorders (PC-FGIDs) has been reported.

Aim:  This case series aimed to investigate the role of homeopathic intervention in the treatment of PC-FGIDs.

Methods:  This is a retrospective analysis of the clinical data of individuals who had suffered from PC-FGIDs that were diagnosed based on clinical symptoms using the Gastrointestinal Symptoms Rating Scale (GSRS) and treated exclusively with individualized homeopathic medicines. Cases that had undergone regular monthly assessment using the GSRS and had a Post-COVID-19 Functional Status (PCFS) score for up to 3 months were considered.

Results:  Thirty cases were screened and twelve were included according to the study criteria. The mean age of seven women and five men was 36 years. GSRS and PCFS scores showed marked improvement in each of 10 cases within the 3-month treatment period.

Conclusion:  Homeopathic intervention proved beneficial in 10 of 12 patients with PC-FGIDs. The findings may help researchers plan future controlled clinical studies in this field.

背景:目的:本病例系列旨在研究顺势疗法干预在治疗PC-FGIDs中的作用:这是一项对PC-FGIDs患者临床数据的回顾性分析,根据临床症状使用胃肠道症状评分量表(GSRS)进行诊断,并完全采用个体化顺势疗法药物进行治疗。每月定期使用胃肠道症状量表(GSRS)对病例进行评估,并在 COVID-19 后对其功能状态(PCFS)进行长达 3 个月的评分:根据研究标准筛选出 30 个病例,其中 12 个病例被纳入研究范围。其中 7 名女性和 5 名男性的平均年龄为 36 岁。在 3 个月的治疗期内,10 个病例的 GSRS 和 PCFS 评分均有明显改善:结论:事实证明,顺势疗法干预对 12 例 PC-FGID 患者中的 10 例有益。结论:顺势疗法干预对 12 例 PC-FGID 患者中的 10 例均有疗效,这些发现可能有助于研究人员规划该领域未来的临床对照研究。
{"title":"Exploring the Role of Homeopathic Intervention in Post-COVID Functional Gastrointestinal Disorders: A Case Series of 12 Patient Profiles.","authors":"Hima Bindu Ponnam, Siva Subrahmanyam Chirravuri, Shanmukha Priya Konduru, Swathi Jammalamadaka","doi":"10.1055/s-0044-1787003","DOIUrl":"10.1055/s-0044-1787003","url":null,"abstract":"<p><strong>Background: </strong> In the last 2 years of the pandemic, a wide range of cases of post-COVID functional gastrointestinal disorders (PC-FGIDs) has been reported.</p><p><strong>Aim: </strong> This case series aimed to investigate the role of homeopathic intervention in the treatment of PC-FGIDs.</p><p><strong>Methods: </strong> This is a retrospective analysis of the clinical data of individuals who had suffered from PC-FGIDs that were diagnosed based on clinical symptoms using the Gastrointestinal Symptoms Rating Scale (GSRS) and treated exclusively with individualized homeopathic medicines. Cases that had undergone regular monthly assessment using the GSRS and had a Post-COVID-19 Functional Status (PCFS) score for up to 3 months were considered.</p><p><strong>Results: </strong> Thirty cases were screened and twelve were included according to the study criteria. The mean age of seven women and five men was 36 years. GSRS and PCFS scores showed marked improvement in each of 10 cases within the 3-month treatment period.</p><p><strong>Conclusion: </strong> Homeopathic intervention proved beneficial in 10 of 12 patients with PC-FGIDs. The findings may help researchers plan future controlled clinical studies in this field.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"195-202"},"PeriodicalIF":1.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterisation of Aqueous Ultra-high Homeopathic Potencies: Nanoparticle Tracking Analysis. 超高顺势疗法药效水剂的特性:纳米粒子跟踪分析。
IF 1.2 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-01 Epub Date: 2024-08-21 DOI: 10.1055/s-0044-1787782
Michel Van Wassenhoven, Martine Goyens, Pierre Dorfman, Philippe Devos, Jean-Louis Demangeat

Background and objectives:  Over the past decade, research using various methods has claimed the material nature, including nanoparticles (NPs), of high homeopathic potencies. The current study aims to verify these findings using NP tracking analysis (NTA).

Methods:  Six independent serial dilutions of commonly used homeopathic medicines-either soluble (Gelsemium, Pyrogenium, Kalium mur) or insoluble (Cuprum, Argentum, Silicea)-were prepared according to European Pharmacopoeia standards. We compared the homeopathic dynamisations (DYNs) in pure water with their potentised controls and with simple dilutions (DIL) up to 30cH/10-60. We also tested the influence of the container (glass or PET) on the solvent controls.

Results:  We observed the presence of particles from 20 to 300-400 nm in all DYNs, DILs and controls, except in pure unstirred water. The sizes and size distributions of NPs in high homeopathic potencies were smaller than those in controls for soluble sources and larger for insoluble sources, even above 11cH. The opposite behaviour was observed in the number of NPs. When comparing DYN and DIL, the number, size, presence of aggregates or chains and brightness of NPs increased with DYNs, which was also observed above 11cH. Many NPs scattered light of low intensity, indicating the presence of material particles. The container had a significant effect on the number and size of NPs, indicating the involvement of the atmosphere and leaching processes.

Conclusion:  Homeopathic medicines contain NPs with specific properties, even when diluted beyond Avogadro's number. Homeopathic potentisation is not a simple dilution. The starting material, the solvent used, the type of container and the manufacturing method influence the characteristics of these NPs. The nature of these NPs is not known, but most likely they are a mixture of nanobubbles and elements from the atmosphere and container, including insoluble ones.

背景和目的:在过去十年中,使用各种方法进行的研究证实了高顺势疗法效力的物质性质,包括纳米颗粒(NPs)。本研究旨在使用 NP 跟踪分析(NTA)验证这些发现:方法:根据欧洲药典标准制备了六种常用顺势疗法药物的独立系列稀释液--可溶的(Gelsemium、Pyrogenium、Kalium mur)或不溶的(Cuprum、Argentum、Silicea)。我们比较了纯净水中的顺势疗法药剂(DYN)与它们的强效对照药剂以及高达 30cH/10-60 的简单稀释液(DIL)。我们还测试了容器(玻璃或 PET)对溶剂对照的影响:我们在所有 DYNs、DILs 和对照品中观察到了从 20 纳米到 300-400 纳米的微粒,纯净水除外。对于可溶源,高顺势药效中 NPs 的尺寸和尺寸分布小于对照组,而对于不溶源,其尺寸和尺寸分布则大于对照组,甚至高于 11cH。在 NPs 的数量方面,观察到了相反的行为。在比较 DYN 和 DIL 时,NPs 的数量、大小、聚集体或链的存在以及亮度都随着 DYN 的增加而增加,这一点在 11cH 以上也能观察到。许多 NP 散射的光强度较低,表明存在物质颗粒。容器对 NPs 的数量和大小有显著影响,表明大气和浸出过程参与其中:顺势疗法药物含有具有特殊性质的 NPs,即使稀释度超过阿伏加德罗数也是如此。顺势疗法的强效化并非简单的稀释。起始材料、所用溶剂、容器类型和制造方法都会影响这些 NPs 的特性。这些 NPs 的性质尚不清楚,但很可能是纳米气泡与大气和容器中的元素(包括不溶性元素)的混合物。
{"title":"Characterisation of Aqueous Ultra-high Homeopathic Potencies: Nanoparticle Tracking Analysis.","authors":"Michel Van Wassenhoven, Martine Goyens, Pierre Dorfman, Philippe Devos, Jean-Louis Demangeat","doi":"10.1055/s-0044-1787782","DOIUrl":"10.1055/s-0044-1787782","url":null,"abstract":"<p><strong>Background and objectives: </strong> Over the past decade, research using various methods has claimed the material nature, including nanoparticles (NPs), of high homeopathic potencies. The current study aims to verify these findings using NP tracking analysis (NTA).</p><p><strong>Methods: </strong> Six independent serial dilutions of commonly used homeopathic medicines-either soluble (<i>Gelsemium</i>, <i>Pyrogenium</i>, <i>Kalium mur</i>) or insoluble (<i>Cuprum</i>, <i>Argentum</i>, <i>Silicea</i>)-were prepared according to European Pharmacopoeia standards. We compared the homeopathic dynamisations (DYNs) in pure water with their potentised controls and with simple dilutions (DIL) up to 30cH/10<sup>-60</sup>. We also tested the influence of the container (glass or PET) on the solvent controls.</p><p><strong>Results: </strong> We observed the presence of particles from 20 to 300-400 nm in all DYNs, DILs and controls, except in pure unstirred water. The sizes and size distributions of NPs in high homeopathic potencies were smaller than those in controls for soluble sources and larger for insoluble sources, even above 11cH. The opposite behaviour was observed in the number of NPs. When comparing DYN and DIL, the number, size, presence of aggregates or chains and brightness of NPs increased with DYNs, which was also observed above 11cH. Many NPs scattered light of low intensity, indicating the presence of material particles. The container had a significant effect on the number and size of NPs, indicating the involvement of the atmosphere and leaching processes.</p><p><strong>Conclusion: </strong> Homeopathic medicines contain NPs with specific properties, even when diluted beyond Avogadro's number. Homeopathic potentisation is not a simple dilution. The starting material, the solvent used, the type of container and the manufacturing method influence the characteristics of these NPs. The nature of these NPs is not known, but most likely they are a mixture of nanobubbles and elements from the atmosphere and container, including insoluble ones.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"146-162"},"PeriodicalIF":1.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12283143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142017302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Eupatorium perfoliatum 30C in Preventing Dengue Fever: A Critical Appraisal. 枯叶泽兰30C预防登革热的有效性评价。
IF 1.2 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-01 Epub Date: 2025-02-25 DOI: 10.1055/s-0044-1801389
Hinpetch Daungsupawong, Viroj Wiwanitkit
{"title":"Effectiveness of Eupatorium perfoliatum 30C in Preventing Dengue Fever: A Critical Appraisal.","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.1055/s-0044-1801389","DOIUrl":"10.1055/s-0044-1801389","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"214"},"PeriodicalIF":1.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143500637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the Letter to the Editor: Effectiveness of Eupatorium perfoliatum 30C in Preventing Dengue Fever: A Critical Appraisal. 致编辑的回复:枯叶泽兰30C预防登革热的有效性:一个关键的评价。
IF 1.2 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-01 Epub Date: 2025-02-25 DOI: 10.1055/s-0044-1801390
Debadatta Nayak, Lovepreet Kaur, Rupali Bhalerao, Karanpreet Nahar, Hanuman Ram, Pawan Sharma, Ankit Gupta, Smita Singh, Anil Khurana, Raj K Manchanda
{"title":"Response to the Letter to the Editor: Effectiveness of Eupatorium perfoliatum 30C in Preventing Dengue Fever: A Critical Appraisal.","authors":"Debadatta Nayak, Lovepreet Kaur, Rupali Bhalerao, Karanpreet Nahar, Hanuman Ram, Pawan Sharma, Ankit Gupta, Smita Singh, Anil Khurana, Raj K Manchanda","doi":"10.1055/s-0044-1801390","DOIUrl":"10.1055/s-0044-1801390","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"215-216"},"PeriodicalIF":1.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143500639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Turning Point for Homeopathy? 顺势疗法的转折点?
IF 1.2 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-01 Epub Date: 2025-07-22 DOI: 10.1055/a-2634-8630
Robert T Mathie
{"title":"A Turning Point for Homeopathy?","authors":"Robert T Mathie","doi":"10.1055/a-2634-8630","DOIUrl":"https://doi.org/10.1055/a-2634-8630","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"114 3","pages":"145"},"PeriodicalIF":1.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144690068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MONARCH Inventory for Causal Attribution in Homeopathy Case Reports: Explanation and Elaboration. 顺势疗法病例报告因果归因的君主量表:解释与阐述。
IF 1.2 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-01 Epub Date: 2024-12-19 DOI: 10.1055/s-0044-1792166
Chetna Deep Lamba, Nidhi Mahajan, Vishwa Kumar Gupta, Lex Rutten, Michael Teut, Lefteris Tapakis, Todd Hoover, Anna Gerstenhoefer, Yuen Ying Yvonne Fok, Rajkumar Manchanda, Robbert van Haselen

Background:  The Modified Naranjo Criteria for Homeopathy (MONARCH) inventory is a novel and useful tool for assessing the likelihood of a causal relationship between the homeopathic intervention and the ultimate clinical outcome.

Objectives:  To explain and elaborate on the use of the MONARCH inventory to improve its consistency of use and thereby elevate the overall quality and evidentiary value of homeopathy case reports.

Explanation and elaboration:  Each of the 10 MONARCH inventory domains is explained and elaborated with the aid of references from published literature and hypothetical clinical situations. The MONARCH total score can range from -6 to +13; within that range, an arithmetic total of +6 is available from the scores of four critical domains, which should be given prominence in the overall consideration of causality. In reporting a clinical case, great importance should be placed on the narrative of the MONARCH evaluation process, domain by domain.

Conclusion:  The application of MONARCH allows us to evaluate the likelihood of a causal relationship between the intervention and the observed clinical outcomes in successfully treated cases, thereby augmenting their evidentiary value.

背景:改良的纳兰霍顺势疗法标准(MONARCH)量表是评估顺势疗法干预与最终临床结果之间因果关系可能性的一种新颖而有用的工具。目的:对君主量表的使用进行解释和阐述,以提高其使用的一致性,从而提高顺势疗法病例报告的整体质量和证据价值。解释和阐述:10个君主库存领域中的每一个都在已发表文献和假设临床情况的参考文献的帮助下进行了解释和阐述。君主的总分可以从-6到+13;在这个范围内,四个关键领域的分数的算术总数为+6,这应该在全面考虑因果关系时给予突出地位。在报告临床病例时,应高度重视君主评估过程的叙述,逐个领域。结论:君主的应用使我们能够评估干预与成功治疗病例观察到的临床结果之间因果关系的可能性,从而增强其证据价值。
{"title":"MONARCH Inventory for Causal Attribution in Homeopathy Case Reports: Explanation and Elaboration.","authors":"Chetna Deep Lamba, Nidhi Mahajan, Vishwa Kumar Gupta, Lex Rutten, Michael Teut, Lefteris Tapakis, Todd Hoover, Anna Gerstenhoefer, Yuen Ying Yvonne Fok, Rajkumar Manchanda, Robbert van Haselen","doi":"10.1055/s-0044-1792166","DOIUrl":"10.1055/s-0044-1792166","url":null,"abstract":"<p><strong>Background: </strong> The Modified Naranjo Criteria for Homeopathy (MONARCH) inventory is a novel and useful tool for assessing the likelihood of a causal relationship between the homeopathic intervention and the ultimate clinical outcome.</p><p><strong>Objectives: </strong> To explain and elaborate on the use of the MONARCH inventory to improve its consistency of use and thereby elevate the overall quality and evidentiary value of homeopathy case reports.</p><p><strong>Explanation and elaboration: </strong> Each of the 10 MONARCH inventory domains is explained and elaborated with the aid of references from published literature and hypothetical clinical situations. The MONARCH total score can range from -6 to +13; within that range, an arithmetic total of +6 is available from the scores of four critical domains, which should be given prominence in the overall consideration of causality. In reporting a clinical case, great importance should be placed on the narrative of the MONARCH evaluation process, domain by domain.</p><p><strong>Conclusion: </strong> The application of MONARCH allows us to evaluate the likelihood of a causal relationship between the intervention and the observed clinical outcomes in successfully treated cases, thereby augmenting their evidentiary value.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"173-182"},"PeriodicalIF":1.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142864124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homeopathy at a Turning Point. 处于转折点的顺势疗法
IF 1.2 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-01 Epub Date: 2024-09-20 DOI: 10.1055/s-0044-1789000
Andrea Dei
{"title":"Homeopathy at a Turning Point.","authors":"Andrea Dei","doi":"10.1055/s-0044-1789000","DOIUrl":"10.1055/s-0044-1789000","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"209-213"},"PeriodicalIF":1.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142286068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Factor Research in Homeopathy: Overview of the Method, with Insights from Condition-Confined Studies. 顺势疗法的预后因素研究:方法概述,以及条件限制研究的见解。
IF 1.3 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-28 DOI: 10.1055/a-2562-8734
Anjali Miglani, Raj Kumar Manchanda, Lex Rutten

A prognostic factor (PF) refers to any feature of a disease or a characteristic of a patient that can be used to predict the likely outcome or course of a disease in an individual. Prognostic factor research (PFR), which is relatively new in homeopathy, focuses on investigating PFs and helps in therapeutic decision-making. The main challenge is the large number of eligible symptoms, but these can be reduced by condition-confined assessment, in which PFR is restricted to sub-populations of patients suffering from the same disease or condition. Condition-confined PFR (CC-PFR) identifies useful medicines for a given disease and compares with great precision different medicines regarding their relationship with common symptoms.To overview PFR and the findings from CC-PFR studies in homeopathy to date.A review of PFR, followed by a summary of six CC-PFR studies in homeopathy for coronavirus disease 2019 (COVID-19) was performed, outlining the methods, the challenges, the interpretation of outcomes and the lessons learned from each of the six studies in considering the further development of this model.The six CC-PFR studies during COVID-19 identified PFs for the 10 most frequently used medicines: Bry, Ars, Puls, Gels, Bell, Hep, Nux-v, Phos, Puls and Rhus-t. These PFs usually contain common symptoms, which in combination become 'specific' enough to select a medicine. These PFs or symptoms also helped to differentiate between these 10 medicines. This model was reproducible and the outcomes were verifiable in the subsequent waves of COVID-19. The outcomes of CC-PFR studies were mostly generalisable and resulted in the preparation of a mini-repertory and repertorisation app. However, these studies revealed key issues. The main problems were the reliability of observations, identification of biases and assessing causality. The quality of PFR data depends on the scientific skills of practitioners, who are typically not trained researchers. Thus, they require additional training in data collection, methods, management of bias and causal analysis.CC-PFR improves the reliable use of common symptoms and thus reduces the inappropriate use of peculiar symptoms based on confirmation bias. CC-PFR studies may be helpful in diseases where rare and peculiar symptoms are difficult to find, for example in one-sided ailments, and in epidemic diseases. PFR, however, requires reliable observations by the participating practitioners. Hence, training and encouragement of clinicians is needed to develop the existing data and integrate research into everyday clinical practice.

预后因素(PF)是指疾病的任何特征或患者的特征,可用于预测个体疾病的可能结果或病程。预后因子研究(prognosis factor research, PFR)是顺势疗法中较新的研究领域,主要研究顺势疗法的预后因子,并帮助制定治疗方案。主要的挑战是有大量符合条件的症状,但这些症状可以通过限制病情的评估来减少,其中PFR仅限于患有相同疾病或病症的患者亚群。条件受限PFR (CC-PFR)确定针对特定疾病的有用药物,并非常精确地比较不同药物与常见症状的关系。概述顺势疗法的PFR和迄今为止CC-PFR研究的结果。对PFR进行了回顾,然后总结了6项CC-PFR顺势疗法治疗2019冠状病毒病(COVID-19)的研究,概述了方法、挑战、结果的解释以及在考虑进一步发展该模型时从6项研究中获得的经验教训。COVID-19期间的六项CC-PFR研究确定了10种最常用药物的pfr: Bry、Ars、Puls、gel、Bell、Hep、Nux-v、Phos、Puls和rus -t。这些PFs通常包含常见症状,这些症状结合在一起变得足够“特异性”,可以选择一种药物。这些PFs或症状也有助于区分这10种药物。该模型具有可重复性,结果在随后的COVID-19浪潮中得到验证。CC-PFR研究的结果大多具有普遍性,并导致了小型储备和储备应用程序的准备。然而,这些研究揭示了关键问题。主要问题是观察结果的可靠性、偏差的识别和因果关系的评估。PFR数据的质量取决于从业人员的科学技能,他们通常不是受过训练的研究人员。因此,他们需要在数据收集、方法、偏差管理和因果分析方面接受额外的培训。CC-PFR提高了对常见症状的可靠使用,从而减少了基于确认偏差的特殊症状的不适当使用。CC-PFR研究可能有助于难以发现罕见和特殊症状的疾病,例如单侧疾病和流行病。然而,PFR需要参与的从业者进行可靠的观察。因此,需要对临床医生进行培训和鼓励,以发展现有数据并将研究纳入日常临床实践。
{"title":"Prognostic Factor Research in Homeopathy: Overview of the Method, with Insights from Condition-Confined Studies.","authors":"Anjali Miglani, Raj Kumar Manchanda, Lex Rutten","doi":"10.1055/a-2562-8734","DOIUrl":"https://doi.org/10.1055/a-2562-8734","url":null,"abstract":"<p><p>A prognostic factor (PF) refers to any feature of a disease or a characteristic of a patient that can be used to predict the likely outcome or course of a disease in an individual. Prognostic factor research (PFR), which is relatively new in homeopathy, focuses on investigating PFs and helps in therapeutic decision-making. The main challenge is the large number of eligible symptoms, but these can be reduced by condition-confined assessment, in which PFR is restricted to sub-populations of patients suffering from the same disease or condition. Condition-confined PFR (CC-PFR) identifies useful medicines for a given disease and compares with great precision different medicines regarding their relationship with common symptoms.To overview PFR and the findings from CC-PFR studies in homeopathy to date.A review of PFR, followed by a summary of six CC-PFR studies in homeopathy for coronavirus disease 2019 (COVID-19) was performed, outlining the methods, the challenges, the interpretation of outcomes and the lessons learned from each of the six studies in considering the further development of this model.The six CC-PFR studies during COVID-19 identified PFs for the 10 most frequently used medicines: <i>Bry, Ars, Puls, Gels, Bell, Hep, Nux-v, Phos, Puls and Rhus-t</i>. These PFs usually contain common symptoms, which in combination become 'specific' enough to select a medicine. These PFs or symptoms also helped to differentiate between these 10 medicines. This model was reproducible and the outcomes were verifiable in the subsequent waves of COVID-19. The outcomes of CC-PFR studies were mostly generalisable and resulted in the preparation of a mini-repertory and repertorisation app. However, these studies revealed key issues. The main problems were the reliability of observations, identification of biases and assessing causality. The quality of PFR data depends on the scientific skills of practitioners, who are typically not trained researchers. Thus, they require additional training in data collection, methods, management of bias and causal analysis.CC-PFR improves the reliable use of common symptoms and thus reduces the inappropriate use of peculiar symptoms based on confirmation bias. CC-PFR studies may be helpful in diseases where rare and peculiar symptoms are difficult to find, for example in one-sided ailments, and in epidemic diseases. PFR, however, requires reliable observations by the participating practitioners. Hence, training and encouragement of clinicians is needed to develop the existing data and integrate research into everyday clinical practice.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144730111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facilitating Healing in Diabetic Foot Ulcers Using Homeopathy in a Multi-Disciplinary Integrative Approach: Two Evidence-Based Case Reports. 在多学科综合疗法中使用顺势疗法促进糖尿病足溃疡的愈合:两例循证病例报告
IF 1.2 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-05-01 Epub Date: 2024-03-05 DOI: 10.1055/s-0044-1779723
Hima Bindu Ponnam

Background:  A rising incidence of diabetic foot ulcers (DFUs) in India has escalated the rate of lower limb amputations in the country. The present study aims to evaluate the potential healing properties of homeopathic medicines as a part of the integrative management of DFUs through two evidence-based case reports.

Methods:  Two patients with DFUs, identified as Wagner grade 2, having had diabetes for 12 years, were treated with individualized homeopathic medicine within a multi-disciplinary approach. Both cases were on oral hypoglycemic agents for managing blood sugar, continued their diabetic medication, and were advised to use regular wound dressings. The DFUs were assessed using the Pressure Ulcer Scale for Healing (PUSH) score at baseline and every 4 weeks until complete wound healing. Neuropathic changes were evaluated by the 10g monofilament tactile test, and the Modified Naranjo Criteria for Homeopathy-Causal Attribution Inventory (MONARCH) tool was used to assess the likelihood of there being a causal relationship between clinical improvement and the homeopathic intervention.

Results:  The DFUs showed healing within 12 weeks, with a significant improvement in the PUSH score, though there was no change in tactile sensation as assessed by the monofilament test. The MONARCH tool yielded +9 in both cases, indicating the likelihood of a causal relationship between the clinical outcome and homeopathic intervention. The homeopathic medicines Arsenicum album and Lachesis respectively were found useful by each patient.

Conclusion:  Homeopathy appeared beneficial in facilitating the early healing of DFUs within a multi-disciplinary integrative approach.

背景:印度糖尿病足溃疡(DFUs)发病率不断上升,导致该国下肢截肢率上升。本研究旨在通过两份循证病例报告,评估顺势疗法药物作为综合治疗糖尿病足溃疡的一部分所具有的潜在治疗特性:两名 DFU 患者被确定为 Wagner 2 级,患糖尿病已有 12 年之久,他们在多学科治疗方法中接受了个性化顺势疗法治疗。两例患者均使用口服降糖药控制血糖,继续服用糖尿病药物,并被建议定期使用伤口敷料。在基线和每 4 周对 DFU 进行一次伤口愈合压力溃疡量表(PUSH)评分,直至伤口完全愈合。通过10克单丝触觉测试评估神经病理性变化,并使用顺势疗法因果归因清单(MONARCH)工具评估临床改善与顺势疗法干预之间存在因果关系的可能性:DFU在12周内痊愈,PUSH评分显著提高,但单丝测试评估的触觉没有变化。两个病例的 MONARCH 工具结果均为 +9,表明临床结果与顺势疗法干预之间可能存在因果关系。每位患者都认为顺势疗法药物砒霜和拉奇斯有用:在多学科综合疗法中,顺势疗法似乎有利于促进 DFU 的早期愈合。
{"title":"Facilitating Healing in Diabetic Foot Ulcers Using Homeopathy in a Multi-Disciplinary Integrative Approach: Two Evidence-Based Case Reports.","authors":"Hima Bindu Ponnam","doi":"10.1055/s-0044-1779723","DOIUrl":"10.1055/s-0044-1779723","url":null,"abstract":"<p><strong>Background: </strong> A rising incidence of diabetic foot ulcers (DFUs) in India has escalated the rate of lower limb amputations in the country. The present study aims to evaluate the potential healing properties of homeopathic medicines as a part of the integrative management of DFUs through two evidence-based case reports.</p><p><strong>Methods: </strong> Two patients with DFUs, identified as Wagner grade 2, having had diabetes for 12 years, were treated with individualized homeopathic medicine within a multi-disciplinary approach. Both cases were on oral hypoglycemic agents for managing blood sugar, continued their diabetic medication, and were advised to use regular wound dressings. The DFUs were assessed using the Pressure Ulcer Scale for Healing (PUSH) score at baseline and every 4 weeks until complete wound healing. Neuropathic changes were evaluated by the 10g monofilament tactile test, and the Modified Naranjo Criteria for Homeopathy-Causal Attribution Inventory (MONARCH) tool was used to assess the likelihood of there being a causal relationship between clinical improvement and the homeopathic intervention.</p><p><strong>Results: </strong> The DFUs showed healing within 12 weeks, with a significant improvement in the PUSH score, though there was no change in tactile sensation as assessed by the monofilament test. The MONARCH tool yielded +9 in both cases, indicating the likelihood of a causal relationship between the clinical outcome and homeopathic intervention. The homeopathic medicines <i>Arsenicum album</i> and <i>Lachesis</i> respectively were found useful by each patient.</p><p><strong>Conclusion: </strong> Homeopathy appeared beneficial in facilitating the early healing of DFUs within a multi-disciplinary integrative approach.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"130-137"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140039205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Homeopathy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1